Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer
Lanxiang Huang, Yuan Rong, Xuan Tang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 242

Showing 1-25 of 242 citing articles:

Exosome biogenesis: machinery, regulation, and therapeutic implications in cancer
Qingfang Han, Wenjia Li, Kaishun Hu, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 308
Engineered exosomes from different sources for cancer-targeted therapy
Menghui Zhang, Shengyun Hu, Lin Liu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 181
Therapeutic cancer vaccines: advancements, challenges and prospects
Ting Fan, Mingna Zhang, Jingxian Yang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 166
Engineered extracellular vesicles and their mimetics for cancer immunotherapy
Chunping Liu, Yichao Wang, Longmei Li, et al.
Journal of Controlled Release (2022) Vol. 349, pp. 679-698
Closed Access | Times Cited: 101
Recent advances in targeted strategies for triple-negative breast cancer
Shuangli Zhu, Yuze Wu, Bin Song, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 95
Cancer Spheroids and Organoids as Novel Tools for Research and Therapy: State of the Art and Challenges to Guide Precision Medicine
Sanae El Harane, Bochra Zidi, Nadia El Harane, et al.
Cells (2023) Vol. 12, Iss. 7, pp. 1001-1001
Open Access | Times Cited: 64
Bioinspired oral delivery devices
Xiaoxuan Zhang, Guopu Chen, Hui Zhang, et al.
Nature Reviews Bioengineering (2023) Vol. 1, Iss. 3, pp. 208-225
Open Access | Times Cited: 46
Ferroptosis and Necroptosis Produced Autologous Tumor Cell Lysates Co-Delivering with Combined Immnoadjuvants as Personalized In Situ Nanovaccines for Antitumor Immunity
Wanrui Shi, Wenjie Feng, Siyuan Li, et al.
ACS Nano (2023) Vol. 17, Iss. 15, pp. 14475-14493
Closed Access | Times Cited: 46
Biomaterials Facilitating Dendritic Cell‐Mediated Cancer Immunotherapy
Heng Dong, Qiang Li, Yu Zhang, et al.
Advanced Science (2023) Vol. 10, Iss. 18
Open Access | Times Cited: 45
Dendritic Cell Vaccines: A Shift from Conventional Approach to New Generations
Kyu-Won Lee, Judy Wai Ping Yam, Xiaowen Mao
Cells (2023) Vol. 12, Iss. 17, pp. 2147-2147
Open Access | Times Cited: 44
Efficient Delivery of GSDMD‐N mRNA by Engineered Extracellular Vesicles Induces Pyroptosis for Enhanced Immunotherapy
Yuqi Xing, Feiyu Zhang, Panpan Ji, et al.
Small (2023) Vol. 19, Iss. 20
Closed Access | Times Cited: 42
Bioengineered Bacterial Membrane Vesicles with Multifunctional Nanoparticles as a Versatile Platform for Cancer Immunotherapy
Xin Zheng Liu, Zhi Juan Wen, Yun Meng Li, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 3, pp. 3744-3759
Closed Access | Times Cited: 40
Roles of exosomes in immunotherapy for solid cancers
C. Lyu, Haifeng Sun, Zhenqiang Sun, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 2
Open Access | Times Cited: 34
Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer
Moumita Kundu, Ramesh Butti, Venketesh K. Panda, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 31
Tumor immune escape: extracellular vesicles roles and therapeutics application
Mahdi Ahmadi, Reza Abbasi, Jafar Rezaie
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 21
Toll‐like receptors in health and disease
Kunyu Wang, Hanyao Huang, Zhan Qi, et al.
MedComm (2024) Vol. 5, Iss. 5
Open Access | Times Cited: 21
Nanomaterial-encapsulated STING agonists for immune modulation in cancer therapy
Xi Chen, Zhijie Xu, Tongfei Li, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 18
Diverse drug delivery systems for the enhancement of cancer immunotherapy: an overview
Xu Liu, Cheng Yang, Yao Mu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 15
Exploring the immuno-nano nexus: A paradigm shift in tumor vaccines
Yuanyuan Li, Yuxing Xu, Wenwen Su, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117897-117897
Closed Access | Times Cited: 1
Porphyrin‐Based Covalent Organic Framework for Imaging‐Guided Cancer Combinatorial Immuno‐Sonodynamic Therapy
Zhixiang Lu, Shuang Bai, Yonghe Jiang, et al.
Advanced Functional Materials (2022) Vol. 32, Iss. 45
Closed Access | Times Cited: 63
Tumor-derived exosomes in the cancer immune microenvironment and cancer immunotherapy
Qiushi Tang, Shuo Yang, Guangpeng He, et al.
Cancer Letters (2022) Vol. 548, pp. 215823-215823
Closed Access | Times Cited: 43
Engineered tumor cell-derived vaccines against cancer: The art of combating poison with poison
Xinyi Zhang, Hengqing Cui, Wenjun Zhang, et al.
Bioactive Materials (2022) Vol. 22, pp. 491-517
Open Access | Times Cited: 43
Tumor-derived exosomes reversing TMZ resistance by synergistic drug delivery for glioma-targeting treatment
Ruoning Wang, Qifan Liang, Xinru Zhang, et al.
Colloids and Surfaces B Biointerfaces (2022) Vol. 215, pp. 112505-112505
Closed Access | Times Cited: 39
Biomineralized hydrogel DC vaccine for cancer immunotherapy: A boosting strategy via improving immunogenicity and reversing immune-inhibitory microenvironment
Wendi Huo, Xinjian Yang, Bei Wang, et al.
Biomaterials (2022) Vol. 288, pp. 121722-121722
Closed Access | Times Cited: 39
Extracellular vesicles remodel tumor environment for cancer immunotherapy
Yue Ming, Shengyun Hu, Haifeng Sun, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 32
Page 1 - Next Page

Scroll to top